1.Adenanthin Induces Differentiation of Acute Promyelocytic Leukemia Cells by Targeting Peroxiredoxin III.
Yun-Xi MO ; Dan-Li LIU ; Shun-Li GAO ; Xiao-Cheng YIN
Journal of Experimental Hematology 2019;27(4):1083-1087
OBJECTIVE:
To investigate the differentiation of acute promyelocytic leukemia (APL) cells induced by adenosine targeting Prx III.
METHODS:
HL-60 cells were divided into four groups: control group, all-trans retinoic acid (ATRA) group, adenanthin group and ATRA+adenanthin group. Cell morphologic changes were observed under optical microscope. The influence of adenanthin on the differentiation of HL-60 was observed by nitro blue tetrazolium chloride (NBT) test. Cell surface differentiation antigens CD11b expression was measured by flow cytometry. The protein expression of Prx III was detected by immunohistochemical assay.
RESULTS:
Adenanthin could induce the differentiation of HL-60 cells; the NBT reduction positive rate in ATRA+adenanthin group was significantly higher than that in ATRA group and adenanthin group (P<0.05). The percentage of CD11b positive cells in ATRA+adenanthin group (43.62%±1.38%) was higher than that in adenanthin group (28.15%±1.78%), ATRA group (36.72%±1.33%) and control group (7.99%±1.78%) (P<0. 05). The content of Prx Ⅲ protein in adenanthin group was significantly higher than that in control group and ATRA group (P<0.05).
CONCLUSION
Adenanthin and ATRA have a synergistic effect on the differentiation and maturation of HL-60 cells, and its mechanism may be related with regulation of Prx III expression.
Cell Differentiation
;
Diterpenes, Kaurane
;
HL-60 Cells
;
Humans
;
Leukemia, Promyelocytic, Acute
;
Peroxiredoxin III
;
Tretinoin
2.The Effects of Peroxiredoxin III on Human HeLa Cell Proliferation.
Immune Network 2003;3(4):276-280
BACKGROUND: Peroxidases (Prx) of the peroxiredoxin family reduce hydrogen peroxide and alkyl hydroperoxides to water and alcohol respectively. Hydrogen peroxide is implicated as an intracellular messenger in various cellular responses such as proliferation and differentiation. And Prx I activity is regulated by Cdc-2 mediated phosphorylation. This work was undertaken to investigate the proliferation role of peroxiredoxin III as a member of Prx family in Prx III overexpressed HeLa cell line. METHODS: To provide further evidence of proliferation, we selected Prx III stably expressed HeLa Tet-off cell lines. Cell proliferation was examined by using proliferation reagent WST-1 in the presence or absence of doxycycline. Prx III, 2-cys Prx enzymes exist as homodimer. The activation of Prx III heterodimer with induced and endogenous Prx III was examined by immunoprecipitation. RESULTS: Immunoprecipitation analysis of the induced and endogenous Prx III with anti-myc showed that the induced wild type (WT) and dominant negative (DN) Prx III from HeLa Prx III Tet-off stable cell heterodimerized with endogenous Prx III each other. And the expression level of induced Prx III was examined after addition of doxycycline. By 72 hr, the expression level of induced Prx III was diminished gradually and the half-life of the induced wild type Prx III was approximately 17 hr. The proliferation experiment demonstrated that the relative proliferation value of induced and endogenous WT Prx III stable cell has no changes but the DN Prx III induced HeLa Tet-off stable cells were lower than endogenous Prx III. CONCLUSION: In conclusion, the HeLa dominant negative Prx III Tet-off stable cells were decreased the proliferation.
Cell Line
;
Cell Proliferation
;
Doxycycline
;
Half-Life
;
HeLa Cells*
;
Humans*
;
Hydrogen Peroxide
;
Immunoprecipitation
;
Peroxidases
;
Peroxiredoxin III*
;
Peroxiredoxins*
;
Phosphorylation
3.Construction of eukaryotic expression plasmid of human PRX3 and its expression in HEK-293FT cells.
Yan FENG ; Zhao LIU ; Huiqing CAO ; Xianmin MENG ; Zhiling QU ; Mi XIONG ; Zhongduan DENG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(4):311-321
To construct the eukaryotic expression plasmid of human PRX3 and measure its expression in the HEK-293FT cells, the full-length coding region of human PRX3 was cloned by PCR and inserted into the eukaryotic expression vector pcDNA4-Xpress (A). HEK-293FT cells were transiently transfected with the recombinant plasmid. Western blot and immuofluorescence were used to detect the expression of the fusion protein. In the experiment, restriction analysis identified the construction of the recombinant plasmid and the inserted sequence was identical with that published on GenBank. Western blot and immunofluorescence confirmed the expression of the recombinant protein in transfected HEK-293FT cells. It was concluded that the eukaryotic expression plasmid of human PRX3 was constructed successfully and the recombinant could be expressed efficiently in HEK-293FT cells, which provides a sound basis for the further study on human PRX3.
Cell Line, Transformed
;
Cloning, Molecular
;
Embryo, Mammalian
;
Eukaryotic Cells
;
metabolism
;
Gene Expression
;
Genetic Vectors
;
Humans
;
Kidney
;
cytology
;
metabolism
;
Peroxidases
;
biosynthesis
;
genetics
;
Peroxiredoxin III
;
Peroxiredoxins
;
Plasmids
;
genetics
;
Transfection
4.MicroRNA383 regulates expression of PRDX3 in human medulloblastomas.
Xiao-mei WANG ; Shi-fen ZHANG ; Zhi-qiang CHENG ; Quan-zhou PENG ; Jin-tao HU ; Li-kun GAO ; Jing XU ; Hong-tao JIN ; Han-yong LIU
Chinese Journal of Pathology 2012;41(8):547-552
OBJECTIVETo investigate the effects of microRNA-383 (miR-383) on PRDX3 gene expression, cell proliferation and apoptosis of human medulloblastma.
METHODSPRDX3 and miR-383 RNA expression was detected by real-time quantitative RT-PCR in human medulloblastoma tumor tissue samples, Daoy cell line and normal brain tissue samples. Western blot was used to detect protein expression of PRDX3. Synthetic miR-383 mimics were transfected into Daoy cells by lipofectamine. Using Cell Counting Kit-8 (CCK-8) method, flow cytometry was used to investigate the cell proliferation and apoptosis, cells reactive oxgen species(ROS), mitochondrial membrane potential changes in each experimental groups.
RESULTSOf 15 cases of human medulloblastoma tumor, 13 cases had miR-383 expression levels significantly lower than that of normal brain tissue, and 14 had PRDX3 mRNA expression levels significantly higher than that of normal brain tissue. The expression levels of miR-383 and PRDX3 in Daoy cells were 0.353 and 1.315 times than those of normal brain tissue, respectively. The protein expression levels of PRDX3 were higher in human medulloblatoma tumors and Daoy cells than that of normal brain tissue. Transfected miR-383 mimics increased the expression level of miR-383 after 24 h and 48 h was significantly higher than that of the control. In contrast, PRDX3 gene mRNA and protein expression levels were significantly decreased at 48 h compared with the control group. Using CCK-8 assay, the cell proliferation rate in the experimental group was significantly lower than that of the control group (P < 0.05). Annexin V-FITC assay demonstrated that early apoptosis rate of the experimental group (11.60 ± 0.30)% was significantly higher than those of the control group (2.3 ± 0.20)% and negative control group (10.37 ± 0.25)% (P = 0.000) after 48 h of transfection. The intracellular ROS levels after transfection at 24 and 48 h significantly increased than those of the control group. Mitochondrial membrane potential level at 24 h after transfection significantly decreased, comparing with the blank control group and the negative control group.
CONCLUSIONSCompared with normal brain tissue, decreased expression of miR-383 but elevated expression of PRDX3 are medulloblastoma tumour and Daoy cell lines. Up-regulation of miR-383 knockdowns the expression of PRDX3, inhibits proliferation and promotes apoptosis of Daoy cells, leading to increased intracellular ROS and decreased levels of mitochondrial membrane potential.
Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Cerebellar Neoplasms ; genetics ; metabolism ; pathology ; Gene Expression Regulation, Neoplastic ; Humans ; Medulloblastoma ; genetics ; metabolism ; pathology ; Membrane Potential, Mitochondrial ; MicroRNAs ; genetics ; metabolism ; Peroxiredoxin III ; genetics ; metabolism ; RNA, Messenger ; metabolism ; Reactive Oxygen Species ; metabolism ; Transfection
5.Nuclear factor E2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer.
Young Sun KIM ; Hye Lim LEE ; Ki Bum LEE ; Joo Hun PARK ; Wou Young CHUNG ; Keu Sung LEE ; Seung Soo SHEEN ; Kwang Joo PARK ; Sung Chul HWANG
The Korean Journal of Internal Medicine 2011;26(3):304-313
BACKGROUND/AIMS: Oxidative stress results in protein oxidation and is implicated in carcinogenesis. Sulfiredoxin (Srx) is responsible for the enzymatic reversal of inactivated peroxiredoxin (Prx). Nuclear factor E2-related factor 2 (Nrf2) binds to antioxidant responsive elements and upregulates the expression of Srx and Prx during oxidative stress. We aimed to elucidate the biological functions and potential roles of Srx in lung cancer. METHODS: To study the roles of Srx and Prx III in lung cancer, we compared the protein levels of Nrf2, Prxs, thioredoxin, and Srx in 40 surgically resected human lung cancer tissues using immunoblot and immunohistochemical analyses. Transforming growth factor-beta1, tumor necrosis factor-alpha, and camptothecin treatment were used to examine Prx III inactivation in Mv1Lu mink lung epithelial cells and A549 lung cancer cells. RESULTS: Prx I and Prx III proteins were markedly overexpressed in lung cancer tissues. A significant increase in the oxidized form of a cysteine sulfhydryl at the catalytic site of Prxs was found in carcinogenic lung tissue compared to normal lung tissue. Densitometric analyses of immunoblot data revealed significant Srx expression, which was higher in squamous cell carcinoma tissue (60%, 12/20) than in adenocarcinoma (20%, 4/20). Also, Nrf2 was present in the nuclear compartment of cancer cells. CONCLUSIONS: Srx and Prx III proteins were markedly overexpressed in human squamous cell carcinoma, suggesting that these proteins may play a protective role against oxidative injury and compensate for the high rate of mitochondrial metabolism in lung cancer.
Adenocarcinoma/*enzymology/genetics/mortality/pathology
;
Animals
;
Antineoplastic Agents, Phytogenic/pharmacology
;
Blotting, Western
;
Camptothecin/pharmacology
;
Carcinoma, Squamous Cell/*enzymology/genetics/mortality/pathology
;
Cell Line, Tumor
;
Humans
;
Immunohistochemistry
;
Lung Neoplasms/*enzymology/genetics/mortality/pathology
;
Mink
;
NF-E2-Related Factor 2/*metabolism
;
Oxidoreductases Acting on Sulfur Group Donors/genetics/*metabolism
;
Peroxiredoxin III/*metabolism
;
Peroxiredoxins/metabolism
;
Prognosis
;
RNA Interference
;
Reactive Oxygen Species/metabolism
;
Transfection
;
Transforming Growth Factor beta1/metabolism
;
Tumor Necrosis Factor-alpha/metabolism
;
Up-Regulation